Immunic Inc.

The momentum for this stock is not very good. Immunic Inc. is not a good value stock. Immunic Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Immunic Inc..
Log in to see more information.

News

Immunic management to meet with Piper Sandler
Immunic management to meet with Piper Sandler

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Immunic, Inc. Forecasted to Earn Q3 2024 Earnings of ($0.22) Per Share (NASDAQ:IMUX)
Immunic, Inc. Forecasted to Earn Q3 2024 Earnings of ($0.22) Per Share (NASDAQ:IMUX)

Ticker Report Immunic, Inc. (NASDAQ:IMUX - Free Report) - Investment analysts at Leerink Partnrs issued their Q3 2024 earnings per share estimates for shares of Immunic in a research report issued to clients and...\n more…

Immunic, Inc. (NASDAQ:IMUX) Expected to Earn Q3 2024 Earnings of ($0.22) Per Share
Immunic, Inc. (NASDAQ:IMUX) Expected to Earn Q3 2024 Earnings of ($0.22) Per Share

Zolmax Immunic, Inc. (NASDAQ:IMUX - Free Report) - Research analysts at Leerink Partnrs issued their Q3 2024 earnings estimates for Immunic in a research note issued on Monday, September 9th. Leerink...\n more…

Brokerages Set Immunic, Inc. (NASDAQ:IMUX) PT at $12.75
Brokerages Set Immunic, Inc. (NASDAQ:IMUX) PT at $12.75

Ticker Report Immunic, Inc. (NASDAQ:IMUX - Get Free Report) has been assigned a consensus recommendation of "Buy" from the six research firms that are covering the company, Marketbeat reports. Five research...\n more…

Immunic, Inc. (NASDAQ:IMUX) Receives $12.75 Consensus PT from Analysts
Immunic, Inc. (NASDAQ:IMUX) Receives $12.75 Consensus PT from Analysts

Zolmax Immunic, Inc. (NASDAQ:IMUX - Get Free Report) has been given a consensus recommendation of "Buy" by the six ratings firms that are presently covering the stock, Marketbeat Ratings reports. Five...\n more…

Immunic management to meet with Piper Sandler
Immunic management to meet with Piper Sandler

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…